|
|
|
|
| LEADER |
03249nmm a2200361 u 4500 |
| 001 |
EB000625292 |
| 003 |
EBX01000000000000001348598 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140122 ||| eng |
| 020 |
|
|
|a 9781461538486
|
| 100 |
1 |
|
|a Allison, Anthony C.
|e [editor]
|
| 245 |
0 |
0 |
|a Vaccines
|h Elektronische Ressource
|b Recent Trends and Progress
|c edited by Anthony C. Allison, Gregory Gregoriadis, George Poste
|
| 250 |
|
|
|a 1st ed. 1991
|
| 260 |
|
|
|a New York, NY
|b Springer US
|c 1991, 1991
|
| 300 |
|
|
|a VIII, 154 p
|b online resource
|
| 505 |
0 |
|
|a Dendritic Cells in the Induction of Immunity -- Escape Mechanisms of Viruses from Immune Responses and Their Relevance to Vaccine Design -- Enhanced Immunogenicity of Recombinant and Synthetic Peptide Vaccines -- Immunomodulation by Adjuvants -- Use of Syntex Adjuvant Formulation to Enhance Immune Responses to Viral Antigens -- Influenza Vaccines and the Wyeth-Ayerst Experience with Syntex Adjuvant -- Nonionic Block Polymer Surfactants as Adjuvants in Vaccines -- Effects of Added Cytokines on Immune Responses and Memory -- The Assessment and Use of Adjuvants -- Efficient Anti-Idiotypic Immunization with Homologous, Virus Neutralizing Monoclonal Antibodies Conjugated with KLH and Combined with Quil A -- Protein Conformation Affects the Efficacy of Pertussis Vaccines -- Vaccination Against Epstein-Barr Virus -- Adenovirus Vectored Vaccines -- Vaccines Against Bacterial Infections of Children -- Current Progress and Future Trends in Birth Control Vaccines -- Contributors
|
| 653 |
|
|
|a Animal Anatomy
|
| 653 |
|
|
|a Anatomy, Comparative
|
| 653 |
|
|
|a Botany
|
| 653 |
|
|
|a Immunology
|
| 653 |
|
|
|a Pharmacology
|
| 653 |
|
|
|a Plant Science
|
| 700 |
1 |
|
|a Gregoriadis, Gregory
|e [editor]
|
| 700 |
1 |
|
|a Poste, George
|e [editor]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b SBA
|a Springer Book Archives -2004
|
| 490 |
0 |
|
|a NATO Science Series A:, Life Sciences
|
| 028 |
5 |
0 |
|a 10.1007/978-1-4615-3848-6
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4615-3848-6?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616,079
|
| 082 |
0 |
|
|a 571.96
|
| 520 |
|
|
|a The success of vaccination in controlling infectious diseases is well documented. However, low profitability, expense and liability have hindered research and development of vaccines. Recently, increasing realization (enhanced by the AIDS pandemic) of the need to overcome such difficulties has led to steps being taken by national authorities, non-profit and commercial organizations to resolve them. This has been facilitated by developments in recombinant DNA techniques, the advent of monoclonal anti bodies and progress in the understanding of the immunological structure of proteins which have laid the foundation of a new generation of vaccines. Such vaccines are defined at the molecular level, can elicit immune responses controlling infectious organisms and are therefore potentially free of the problems encountered in conventional ones. Unfortunately, subunit and synthetic peptide vaccines are often only weakly or non inmunogenic. However, developments in both antigen production and immuno potentiation of weak antigens have opened new avenues with exciting prospects for vaccine design
|